We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Safety Insurance
SAFT
$1.52B
| $3.59M | ﹤0.01% |
47,294
+1,067
| +2% | +$80.5K |
|
1602
Lucid Motors
LCID
$2.77B
| $3.59M | ﹤0.01% |
85,266
+745
| +0.9% | +$33.4K |
|
1603
Twist Bioscience
TWST
$7.25B
| $3.59M | ﹤0.01% |
97,294
-250
| -0.3% | -$5.78K |
|
1604
Denali Therapeutics
DNLI
$3.97B
| $3.58M | ﹤0.01% |
166,763
-2,361
| -1% | -$46.8K |
|
1605
Wabash National
WNC
$527M
| $3.57M | ﹤0.01% |
139,336
+2,559
| +2% | +$57.8K |
|
1606
UFP Technologies
UFPT
$2.43B
| $3.57M | ﹤0.01% |
20,744
-259
| -1% | -$41.9K |
|
1607
Embecta
EMBC
$262M
| $3.57M | ﹤0.01% |
188,467
+3,305
| +2% | +$54.2K |
|
1608
RLJ Lodging Trust
RLJ
$1.69B
| $3.56M | ﹤0.01% |
303,941
-27
| -0% | -$281 |
|
1609
IonQ
IONQ
$16.6B
| $3.56M | ﹤0.01% |
287,148
+22,828
| +9% | +$294K |
|
|
CBAY
1610
DELISTED
Cymabay Therapeutics
CBAY
| $3.55M | ﹤0.01% |
150,169
+20,665
| +16% | +$368K |
|
|
FBRT
1611
Franklin BSP Realty Trust
FBRT
$657M
| $3.54M | ﹤0.01% |
261,977
-3,124
| -1% | -$41.2K |
|
|
HA
1612
DELISTED
Hawaiian Holdings, Inc.
HA
| $3.54M | ﹤0.01% |
249,159
+51,361
| +26% | +$381K |
|
1613
Eastern Bankshares
EBC
$5.23B
| $3.54M | ﹤0.01% |
249,071
-532
| -0.2% | -$6.64K |
|
1614
Remitly
RELY
$5.14B
| $3.53M | ﹤0.01% |
181,829
+4,288
| +2% | +$96.1K |
|
1615
iShares MSCI UAE ETF
UAE
$321M
| $3.51M | ﹤0.01% |
236,072
+27,100
| +13% | +$395K |
|
|
LGTY
1616
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $3.51M | ﹤0.01% |
310,213
-5,745
| -2% | -$61.7K |
|
|
AVNS
1617
DELISTED
Avanos Medical
AVNS
| $3.5M | ﹤0.01% |
155,948
+367
| +0.2% | +$7.58K |
|
1618
Novartis
NVS
$297B
| $3.49M | ﹤0.01% |
34,581
+398
| +1% | +$38.4K |
|
1619
Coursera
COUR
$1.54B
| $3.48M | ﹤0.01% |
179,724
-273
| -0.2% | -$5.22K |
|
1620
Q2 Holdings
QTWO
$3.92B
| $3.48M | ﹤0.01% |
80,185
-1,448
| -2% | -$51.4K |
|
1621
Scholastic
SCHL
$792M
| $3.48M | ﹤0.01% |
92,216
-2,701
| -3% | -$103K |
|
1622
Teva Pharmaceuticals
TEVA
$41.2B
| $3.47M | ﹤0.01% |
332,792
+33,792
| +11% | +$315K |
|
1623
Ambarella
AMBA
$3.81B
| $3.47M | ﹤0.01% |
56,673
+661
| +1% | +$36.1K |
|
|
SWTX
1624
DELISTED
SpringWorks Therapeutics
SWTX
| $3.47M | ﹤0.01% |
95,064
+8,672
| +10% | +$226K |
|
1625
iShares MSCI Qatar ETF
QAT
$64M
| $3.47M | ﹤0.01% |
191,307
+1,858
| +1% | +$31.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.